MedTrace Logo

Radiotherapy-Associated Atrial Fibrillation

NCT05927246 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-07-03

No results posted yet for this study

Summary

Radiotherapy associated Atrial Fibrillation (RADAF) is an observational study to evaluate onset time and frequency of atrial fibrillation in patients with thoracic malignancies and breast cancer.

Each patient will have 12 lead ECG prior, and daily during radiotherapy.

Conditions

  • Atrial Fibrillation New Onset

Interventions

DIAGNOSTIC_TEST

ECG

12 lead ecg for each participant

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Cafer Zorkun, MD PhD · Faculty member

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05927246 on ClinicalTrials.gov